Mark Fielding

Mark Fielding has a robust background in regulatory affairs, primarily within the pharmaceutical industry, holding notable positions at AstraZeneca from November 2017 to February 2022, where responsibilities included leading regulatory CMC project teams and developing global regulatory strategies for marketing applications and clinical trials. Prior experience includes a role as a Research Associate at the University of Texas at Austin from January 2001 to October 2002 and a position as a Process Development Chemist at Hickson & Welch Fine Chemicals from August 1996 to September 1997. Mark began his career at Merck as a Sandwich Student from August 1994 to September 1995. Mark holds a PhD from the University of Leeds and a Bachelor's Degree from the University of Leicester.